← SearchRapid Non-Viral Platform for Generation of Genetically Modified T Cells for Therapy$218,588R44FY2018CANIHB-Mogen Biotechnologies, Inc., Minneapolis MNInvestigatorsDavid L Lampi HermansoncontactView original record on NIH RePORTER →